These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38098840)

  • 1. Case report: Area of focus of management of severe pityriasis rubra pilaris by dose optimization of adalimumab biosimilar in combination with acitretin and montelukast.
    Heidemeyer K; Seyed Jafari SM; Farnina L; Bossart S; Feldmeyer L; Yawalkar N
    Front Med (Lausanne); 2023; 10():1295777. PubMed ID: 38098840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late onset pityriasis rubra pilaris type IV treated with low-dose acitretin.
    Mota F; Carvalho S; Sanches M; Selores M
    Acta Dermatovenerol Alp Pannonica Adriat; 2016; 25(1):15-7. PubMed ID: 27014774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent Pityriasis Rubra Pilaris: A Case Report.
    MacGillivray ME; Fiorillo L
    J Cutan Med Surg; 2018; 22(6):624-626. PubMed ID: 29754526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circumscribed Juvenile Pityriasis Rubra Pilaris (Type 4) Koebnerising after a Hot Water Burn: Mild Disease with Maximum Koebner Response.
    Acar EM; Has S; Kilitci A; Kemeriz F
    Acta Dermatovenerol Croat; 2019 Mar; 27(1):47-49. PubMed ID: 31032794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate treatment in a case of juvenile pityriasis rubra pilaris.
    Boyd AH; Polcari IC
    Pediatr Dermatol; 2018 Jan; 35(1):e62-e63. PubMed ID: 29044698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pityriasis rubra pilaris partially responsive to treatment with upadacitinib: A case report.
    Saad M; Spurr A; Lipson J
    SAGE Open Med Case Rep; 2023; 11():2050313X231160927. PubMed ID: 37009550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adalimumab for the treatment of pityriasis rubra pilaris: a case report.
    Wassef C; Lombardi A; Rao BK
    Cutis; 2012 Nov; 90(5):244-7. PubMed ID: 23270195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrodermic pityriasis rubra pilaris treatment: Two case reports and literature review.
    Camela E; Miano C; Di Caterino P; Lo Presti M; De Fata Salvatores G; Fabbrocini G; Megna M
    Dermatol Ther; 2020 Nov; 33(6):e14223. PubMed ID: 32820849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractory pityriasis rubra pilaris treated with etanercept, adalimumab, or ustekinumab: A retrospective investigation.
    Maloney NJ; Hisaw LD; Worswick S
    Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 29034547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review on Pityriasis Rubra Pilaris.
    Wang D; Chong VC; Chong WS; Oon HH
    Am J Clin Dermatol; 2018 Jun; 19(3):377-390. PubMed ID: 29302927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris.
    Di Stefani A; Galluzzo M; Talamonti M; Chiricozzi A; Costanzo A; Chimenti S
    J Dermatol Case Rep; 2013 Mar; 7(1):5-9. PubMed ID: 23580907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of a child's pityriasis rubra pilaris (PRP) with ustekinumab and acitretin.
    Katharina M; Sylvia S; Matthias B; Ulrich M; Martin L
    Pediatr Dermatol; 2022 Jul; 39(4):659-661. PubMed ID: 35859269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of refractory pityriasis rubra pilaris: challenges and solutions.
    Moretta G; De Luca EV; Di Stefani A
    Clin Cosmet Investig Dermatol; 2017; 10():451-457. PubMed ID: 29184428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraneoplastic Pityriasis Rubra Pilaris Preceding Leukemia.
    Vance P; Wyles S; Alavi A
    Adv Skin Wound Care; 2022 Jun; 35(6):1-4. PubMed ID: 35703855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of pityriasis rubra pilaris with adalimumab - case report.
    Bravo EA; Carrion L; Paucar SM; Mendoza R; Rivera C
    Dermatol Online J; 2014 Apr; 20(4):22374. PubMed ID: 24746310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of severe pityriasis rubra pilaris with secukinumab in a 3-year-old boy.
    Xu YH; Dong DD; Lin YF; Wang Q; Huang LM; Shi JQ
    Clin Exp Dermatol; 2022 Nov; 47(11):2043-2045. PubMed ID: 35906074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Treatment of Pityriasis Rubra Pilaris with Risankizumab in Children.
    Kołt-Kamińska M; Osińska A; Kaznowska E; Reich A
    Dermatol Ther (Heidelb); 2023 Oct; 13(10):2431-2441. PubMed ID: 37704911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful Treatment of Pityriasis Rubra Pilaris with Ixekizumab.
    Hanfstingl K; Pekar-Lukacs A; Motz R; Guenova E; Hoetzenecker W
    Case Rep Dermatol; 2018; 10(2):97-100. PubMed ID: 29867429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pityriasis rubra pilaris sensitive to narrow band-ultraviolet B light therapy.
    Vergilis-Kalner IJ; Mann DJ; Wasserman J; Petronic-Rosic V; Tsoukas MM
    J Drugs Dermatol; 2009 Mar; 8(3):270-3. PubMed ID: 19271375
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.